Keyword: Human Genome Science
News
26.08.2013
- Amgen struck a deal to buy cancer drug maker Onyx Pharmaceuticals for about $10.4 billion on Sunday, as it moves to restock its product pipeline in response to declining sales of...
News
07.07.2012
- Celgene is one of two companies discussing whether to bid for Human Genome Sciences, which seeks an alternative to a hostile offer by British drugmaker GlaxoSmithKline, a source...
News
23.04.2012
- AstraZeneca has agreed to buy U.S. company Ardea Biosciences for $1.26 billion, giving it a new gout drug to bolster its weak pipeline in a deal that feeds a wave of M&A in the...
